PET drug administration

6 trials

Sponsors

Watabe Tadashi, Matsuoka Ken, Osaka University Graduate School of Medicine

Conditions

Head and neck cancerLung cancer LAT1 PET diagnosisMalignant tumorMyocarditis-group diseases and Non-myocarditis-group diseases VLA-4-targeted PET diagnosis of Lymphocytic MyocarditisNormal healthy volunteer LAT1 PET diagnosisNormal healthy volunteer VLA-4 PET diagnosis

Phase 1

Safety evaluation of PET probe F18-NKO-035

Active, not recruitingJPRN-jRCTs051190057

Watabe TadashiNormal healthy volunteer LAT1 PET diagnosis

Start: 2019-11-14Target: 4Updated: 2026-06-29

Safety evaluation of VLA-4-targeted PET probe

Active, not recruitingJPRN-jRCTs051250020

Watabe TadashiNormal healthy volunteer VLA-4 PET diagnosis

Start: 2025-05-12Target: 3Updated: 2026-06-29

Phase 2

Usefulness evaluation of PET probe F18-NKO-035

Active, not recruitingJPRN-jRCTs051200075

Watabe TadashiLung cancer LAT1 PET diagnosis

Start: 2020-10-27Target: 12Updated: 2026-06-29

Utility evaluation of VLA-4-targeted PET probe

RecruitingJPRN-jRCTs051260088

Matsuoka KenMyocarditis-group diseases and Non-myocarditis-group diseases VLA-4-targeted PET diagnosis of Lymphocytic Myocarditis

Start: 2026-07-01Target: 50Updated: 2026-09-14

Unknown Phase

Evaluation of L-type amino acid transporter 1 (LAT1) expression by F-18 FBPA PET

Active, not recruitingJPRN-UMIN000036478

Osaka University Graduate School of MedicineMalignant tumor

Start: 2019-05-01Target: 100Updated: 2026-06-29

A comparative study of F-18 FBPA-PET and F-18 FDG-PET in head and neck cancer

RecruitingJPRN-UMIN000049242

Osaka University Graduate School of MedicineHead and neck cancer

Start: 2023-01-01Target: 85Updated: 2026-06-29